Fri.May 10, 2024

article thumbnail

House's updated biosecurity bill sets 2032 decoupling deadline for industry's work with WuXi AppTec

Fierce Pharma

Right after an industry survey suggested that switching away from Chinese CDMOs could take biopharma companies up to eight years, lawmakers have adjusted the BIOSECURE Act. | Right after an industry survey suggested that switching away from Chinese CDMOs could take biopharma companies up to eight years, lawmakers have adjusted the BIOSECURE Act. The new draft lays out a 2032 deadline for the separation mandate.

Biopharma 339
article thumbnail

Challenges and opportunities in the CGT supply chain

European Pharmaceutical Review

the success of CGT depends on a robust and reliable supply chain” Cell and gene therapies (CGT) offer a revolutionary approach to the treatment, prevention and potential cure of diseases. These advanced medical treatments provide hope for patients suffering from conditions that have historically been poorly understood and widely considered incurable, including genetic diseases and cancers.

Medicine 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sanofi keeps Novavax afloat with $1.2B bet on its vaccine platform

Fierce Pharma

After years of missteps in developing and commercializing its coronavirus shot, Novavax is turning to one of the biopharma industry’s most experienced vaccine companies to help salvage its COVID ef | After years of missteps in developing and commercializing its coronavirus shot, Novavax is turning to one of the biopharma industry’s most experienced vaccine companies to help salvage its COVID efforts.

Biopharma 290
article thumbnail

Sanofi forges $1.2bn alliance with vaccines firm Novavax

pharmaphorum

Sanofi has licensed joint commercial rights to Novavax’s COVID-19 vaccine and will work with the biotech on the development of combined flu/COVID shots in a deal worth up to $1.2 billion.

105
105
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

AGC Biologics plots roughly 100 layoffs as CDMO industry's post-COVID hangover persists

Fierce Pharma

While some biopharma contract manufacturers have been able to weather a tough business environment in recent months, many others continue to struggle against financing headwinds affecting the great | AGC Biologics, which employs more than 2,500 workers worldwide, has “had to reduce positions at our Seattle and Colorado sites and global functional areas,” a spokesperson confirmed Friday in an emailed statement.

Biopharma 273
article thumbnail

Small Thank You’s Mean a Lot: The Impact of Micropayments in Clinical Trials

MedCity News

Micropayments provide an additional incentive for patients to complete required tests, procedures, and diary entries, ensuring that sites, sponsors, and CROs are able to collect the required data needed to complete a clinical trial on time and on budget. The post Small Thank You’s Mean a Lot: The Impact of Micropayments in Clinical Trials appeared first on MedCity News.

Patients 109

More Trending

article thumbnail

StartUPDATES: New Developments from Healthcare Startups

MedCity News

Check out news from Alpha Sophia, Triomics, In-House Health, and Humanaut Health. The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.

article thumbnail

Shionogi secures licence for Maze’s Pompe disease treatment

Pharmaceutical Technology

Shionogi has concluded an exclusive global licence agreement for Maze Therapeutics’ MZE001 aimed at treating Pompe disease.

105
105
article thumbnail

This Chip Seeks to Transform Drug Manufacturing by Learning More About Intracellular Dynamics

MedCity News

A new startup launched at the SynBioBeta conference. The company, called CybergenX, is seeking to integrate AI-powered cybergenetic technology into the synthetic biology field. By doing this, CybergenX is seeking to accelerate the potential of engineering biology in drug manufacturing. The post This Chip Seeks to Transform Drug Manufacturing by Learning More About Intracellular Dynamics appeared first on MedCity News.

article thumbnail

Maze gets new Pompe partner after FTC blocks Sanofi deal

pharmaphorum

Five months after Sanofi walked away from a deal with Maze Therapeutics on an oral Pompe disease therapy, Shionogi has snapped up the drug.

99
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

How to Interview Healthcare Experts to Write Exceptional Website Content

Healthcare Success

Interviewing medical experts is a tried-and-true way to produce original website content. Without that first-hand, unique, and accurate medical knowledge, your content can unintentionally mislead consumers, damage your reputation, and lose search engine rankings. But what if the experts your organization needs are busy doctors? Or you need help building a content strategy?

article thumbnail

Bluejay hatches $182m funding egg for hepatitis drugs

pharmaphorum

Bluejay Therapeutics has raised $182 million for clinical trials of its drug candidate for hepatitis D and B

95
article thumbnail

NHS reduces long waits for cancer care and achieves faster ambulance responses

PharmaTimes

For the second month in a row, the NHS has met the 28-day faster diagnosis target for cancer

87
article thumbnail

Pharma Pulse 5/10/24: Where Is the AI Boom Taking Us? Drug Recalls & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

MHRA’s AI Airlock to address challenges for regulating AI medical devices

PharmaTimes

The sandbox will help to inform future AI Airlock projects and influence future AlaMD guidance

Medical 75
article thumbnail

The Future of Medical Sales Careers: Trends, Challenges, and Opportunities

Rep-Lite

The world of medical sales is bursting with change. From groundbreaking advancements in technology to a growing emphasis on patient-centricity, the industry is constantly evolving. This presents a dynamic environment for whether you are an aspiring and seasoned medical sales rep. Staying abreast of these trends helps both the reps looking to land their dream job, as well as the employers seeking top talent.

article thumbnail

Sanofi, Novavax to Co-Commercialize COVID-19 Vaccine

Pharmaceutical Commerce

Parties sign co-exclusive licensing agreement, which includes a minority equity investment in Novavax, who will be receiving payments totaling as high as $1.2 billion when combining upfront payment and milestones.

52
article thumbnail

A Meeting of Minds: Tyler Cameron and the Power of Vision, Mindset, and Grit

Scott Burrows

In the charming town of Jupiter, Florida, where the sun dances on the water and dreams seem within arm’s reach, chance encounters often hold the promise of inspiration. Such was the case when I had the pleasure of crossing paths with Tyler Cameron, a man whose vision, mindset, and grit epitomize the essence of resilience and determination. Some of you may know Tyler Cameron from his time on ABC’s The Bachelorette Season 15 – known not just for his charm and good looks but also for hi

52
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Addressing Unmet Needs with LP-284 for Relapsed/Refractory Lymphomas and Solid Tumors

PharmExec

In this Pharmaceutical Executive video interview, Panna Sharma, CEO, Lantern Pharma, discusses how LP-284 uniquely addresses unmet needs compared to existing or emerging treatments for relapsed/refractory lymphomas and solid tumors.

Pharma 52
article thumbnail

VUE Health Welcomes Zara Baker as Chief Digital Innovation Officer

PM360

Zara Baker as Chief Digital Innovation Officer, VUE Health BOSTON, Mass., May 9, 2024 /PRNewswire/ — VUE Health, a Boston-based healthcare advertising agency, has hired Zara Baker as Chief Digital Innovation Officer. Zara is an MIT-trained innovator and a former scientist with over two decades of healthcare and life science industry experience that spans the US and EU markets within agency and corporate environments.

article thumbnail

Yvonne Greenstreet: Answering the Call

PharmExec

From Big Pharma to biotech—and a globe-spanning journey along the way—Yvonne Greenstreet, this year’s Healthcare Businesswomen’s Association Woman of the Year, is right where she wants to be: leading efforts to advance “bold ideas” in RNAi therapeutics into life-changing gains for patients.

Pharma 52
article thumbnail

Oral solid dosage manufacturing companies, equipment and market

Pharmaceutical Technology

Discover key insights into the selection of oral solid dosage manufacturing companies and equipment. Learn about the latest technological advancements in the oral solid dosage industry and market.

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Avoiding the Digital Age is Hurting Research Efforts

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

RAPT terminates Phase II trials for lead candidate following clinical hold

Pharmaceutical Technology

RAPT is closing two Phase II trials for Rapt’s lead candidate, zelnecirnon, three months after the FDA placed a clinical hold on them.

Leads 59
article thumbnail

Biotech’s Road to Recovery Takes a Wobbly Turn

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Four ways the vaccine rush will define infectious disease trends for CROs in 2024

Pharmaceutical Technology

GlobalData examines four of the key trends affecting contract research organizations (CROs) involved with infectious diseases.

59
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Pharma Pulse 5/10/24: Medicare Advantage, Racing Along, Hits Some Speed Bumps, Anti-Obesity Drugs Global Strategic Business Report & more

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52
article thumbnail

Formosa and Tabuk sign deal for FDA-approved ophthalmic suspension

Pharmaceutical Technology

Tabuk obatined rights to commercialise Formosacs l'obetasol propionate ophthalmic suspension 0.05% for inflammation after ocular surgery.

FDA 52
article thumbnail

CVS Health Survey Says Mental Health Concerns Continue to Rise Post Pandemic

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

FDA Approves sBLA for Adalimumab-adaz as Interchangeable Biosimilar for Humira

Pharmacy Times

A provisional determination is also provided for the 40 mg/0.4 mL strength due to remaining interchangeability designation for another biosimilar to Humira.

FDA 61
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A